Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Julie A. Panepinto MD, MSPH

Julie A. Panepinto MD, MSPH

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Hematology

Member of the Cancer Center
Member of the Center For Patient Care and Outcomes Research (PCOR)


I am willing to mentor a junior faculty member.


Clinical Expertise

  • Anemia, Sickle Cell
  • Hematology
  • Publications

  • Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2015 Sep;62(9):1501-11 PMID: 25976161 PMCID: PMC4515148
  • Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Hematology Am Soc Hematol Educ Program 2014 Dec 5;2014(1):599-603 PMID: 25696917
  • A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale. (Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Apr;37(3):190-4 PMID: 25575295
  • Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Blood 2014 Dec 4;124(24):3524-8 PMID: 25472968
  • Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. (Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA, SIT trial investigators) Am J Hematol 2015 Feb;90(2):139-43 PMID: 25345798 PMCID: PMC4304929
  • The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay. (Brandow AM, Farley RA, Dasgupta M, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Jan;37(1):10-5 PMID: 25222053 PMCID: PMC4270887
  • Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. (DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF) N Engl J Med 2014 Aug 21;371(8):699-710 PMID: 25140956 PMCID: PMC4195437
  • Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. (King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR) Am J Hematol 2014 Oct;89(10):E188-92 PMID: 25042018 PMCID: PMC4261188
  • Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease. (Beverung LM, Varni JW, Panepinto JA) J Pediatr Hematol Oncol 2015 Mar;37(2):128-33 PMID: 24942019 PMCID: PMC4269583
  • Ambulatory quality indicators to prevent infection in sickle cell disease. (Beverung LM, Brousseau D, Hoffmann RG, Yan K, Panepinto JA) Am J Hematol 2014 Mar;89(3):256-60 PMID: 24779032 PMCID: PMC4450348
  • Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease. (Wiczling P, Liem RI, Panepinto JA, Garg U, Abdel-Rahman SM, Kearns GL, Neville KA) J Clin Pharmacol 2014 Sep;54(9):1016-22 PMID: 24729271
  • Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. (Badaki-Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, Pediatric Emergency Care Applied Research Network (PECARN) Magnesium in Sickle Cell Crisis (MAGiC) Study Group) Pediatr Blood Cancer 2014 Jun;61(6):1049-54 PMID: 24443249 PMCID: PMC3995128
  • Neuropathic pain in patients with sickle cell disease. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2014 Mar;61(3):512-7 PMID: 24167104 PMCID: PMC4357477
  • PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. (Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW) Pediatr Blood Cancer 2014 Jan;61(1):171-7 PMID: 24038960 PMCID: PMC3848797
  • Academic attainment findings in children with sickle cell disease. (Epping AS, Myrvik MP, Newby RF, Panepinto JA, Brandow AM, Scott JP) J Sch Health 2013 Aug;83(8):548-53 PMID: 23834606
  • Clinically meaningful measurement of pain in children with sickle cell disease. (Myrvik MP, Brandow AM, Drendel AL, Yan K, Hoffmann RG, Panepinto JA) Pediatr Blood Cancer 2013 Oct;60(10):1689-95 PMID: 23776145 PMCID: PMC3993972
  • Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion. (Collins CL, Scott JP, Panepinto JA, Punzalan RC) J Pediatr Hematol Oncol 2013 Jul;35(5):e226-8 PMID: 23459377
  • Assessment of communication modes in patients and families with sickle cell disease. (Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA) Pediatr Blood Cancer 2013 May;60(5):887 PMID: 23450782
  • PedsQL™ sickle cell disease module: feasibility, reliability, and validity. (Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW) Pediatr Blood Cancer 2013 Aug;60(8):1338-44 PMID: 23441057 PMCID: PMC4412167
  • Health-related quality of life in patients with hemoglobinopathies. (Panepinto JA) Hematology Am Soc Hematol Educ Program 2012;2012:284-9 PMID: 23233593
  • What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease? (Darbari DS, Panepinto JA) Hematology Am Soc Hematol Educ Program 2012;2012:290-1 PMID: 23233594
  • Mental health disorders influence admission rates for pain in children with sickle cell disease. (Myrvik MP, Burks LM, Hoffman RG, Dasgupta M, Panepinto JA) Pediatr Blood Cancer 2013 Jul;60(7):1211-4 PMID: 23151972
  • Patients with sickle cell disease have increased sensitivity to cold and heat. (Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA) Am J Hematol 2013 Jan;88(1):37-43 PMID: 23115062 PMCID: PMC3552380
  • Health-related quality of life in sickle cell disease: past, present, and future. (Panepinto JA, Bonner M) Pediatr Blood Cancer 2012 Aug;59(2):377-85 PMID: 22522407
  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 PMID: 22343376 PMCID: PMC3618440
  • Inpatient management of sickle cell pain: a 'snapshot' of current practice. (Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)) Am J Hematol 2012 Mar;87(3):333-6 PMID: 22231150
  • Concentration of hospital care for acute sickle cell disease-related visits. (Panepinto JA, Owens PL, Mosso AL, Steiner CA, Brousseau DC) Pediatr Blood Cancer 2012 Oct;59(4):685-9 PMID: 22180290 PMCID: PMC3310931
  • Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. (DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF) Blood 2012 Apr 19;119(16):3684-90 PMID: 22096242 PMCID: PMC3335377
  • When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department. (Hemker BG, Brousseau DC, Yan K, Hoffmann RG, Panepinto JA) Am J Hematol 2011 Oct;86(10):863-5 PMID: 21815184
  • Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. (Brandow AM, Panepinto JA) Am J Hematol 2011 Sep;86(9):804-6 PMID: 21815183 PMCID: PMC3804029
  • Development of the PedsQL™ Sickle Cell Disease Module items: qualitative methods. (Panepinto JA, Torres S, Varni JW) Qual Life Res 2012 Mar;21(2):341-57 PMID: 21638090 PMCID: PMC3277645
  • Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. (Thornburg CD, Calatroni A, Panepinto JA) J Pediatr Hematol Oncol 2011 May;33(4):251-4 PMID: 21516020 PMCID: PMC3729442
  • Outpatient follow-up and rehospitalizations for sickle cell disease patients. (Leschke J, Panepinto JA, Nimmer M, Hoffmann RG, Yan K, Brousseau DC) Pediatr Blood Cancer 2012 Mar;58(3):406-9 PMID: 21495162
  • The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM, Weisman SJ, Panepinto JA) Pediatr Blood Cancer 2011 May;56(5):789-93 PMID: 21370412 PMCID: PMC3069506
  • Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. (Brandow AM, Panepinto JA) Expert Rev Hematol 2010 Jun;3(3):255-60 PMID: 21082977 PMCID: PMC3793890
  • Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. (Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR) Blood 2011 Jan 20;117(3):772-9 PMID: 20940417 PMCID: PMC3035071
  • Transition From Pediatric to Adult Care for Patients With Sickle Cell Disease-Reply. (Brousseau DC, Panepinto JA, Steiner CA) JAMA 2010 Jul 28;304(4):408-409 PMID: 22618679
  • Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. (Brandow AM, Jirovec DL, Panepinto JA) Am J Hematol 2010 Aug;85(8):611-3 PMID: 20658592 PMCID: PMC2911651
  • The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease. (Panepinto JA, Hoffmann RG, Pajewski NM) Pediatr Blood Cancer 2010 Oct;55(4):714-21 PMID: 20589646 PMCID: PMC3835190
  • Acute care utilization and rehospitalizations for sickle cell disease. (Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA) JAMA 2010 Apr 7;303(13):1288-94 PMID: 20371788
  • The number of people with sickle-cell disease in the United States: national and state estimates. (Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG) Am J Hematol 2010 Jan;85(1):77-8 PMID: 20029951
  • Vaso-occlusive painful events in sickle cell disease: impact on child well-being. (Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA) Pediatr Blood Cancer 2010 Jan;54(1):92-7 PMID: 19653296 PMCID: PMC3114448
  • A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease. (Panepinto JA, Hoffmann RG, Pajewski NM) Health Qual Life Outcomes 2009;7:32 PMID: 19371442 PMCID: PMC2678996
  • Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease. (Brousseau DC, Mukonje T, Brandow AM, Nimmer M, Panepinto JA) Pediatr Blood Cancer 2009 Aug;53(2):174-8 PMID: 19350642
  • Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. (Brandow AM, Brousseau DC, Panepinto JA) Br J Haematol 2009 Mar;144(5):782-8 PMID: 19055663 PMCID: PMC3118502
  • Impact of family income and sickle cell disease on the health-related quality of life of children. (Panepinto JA, Pajewski NM, Foerster LM, Sabnis S, Hoffmann RG) Qual Life Res 2009 Feb;18(1):5-13 PMID: 18989755 PMCID: PMC2840660
  • The performance of the PedsQL generic core scales in children with sickle cell disease. (Panepinto JA, Pajewski NM, Foerster LM, Hoffmann RG) J Pediatr Hematol Oncol 2008 Sep;30(9):666-73 PMID: 18776758 PMCID: PMC2667700
  • Parental perception of quality of hospital care for children with sickle cell disease. (Kam J, Panepinto JA, Brandow AM, Brousseau DC) WMJ 2008 May;107(3):131-5 PMID: 18575097
  • Health-related quality of life in sickle cell disease. (Panepinto JA) Pediatr Blood Cancer 2008 Jul;51(1):5-9 PMID: 18338399
  • The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis. (Brousseau DC, McCarver DG, Drendel AL, Divakaran K, Panepinto JA) J Pediatr 2007 Jun;150(6):623-6 PMID: 17517247 PMCID: PMC1978168
  • Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. (Goers T, Panepinto J, Debaun M, Blinder M, Foglia R, Oldham KT, Field JJ) Pediatr Blood Cancer 2008 Mar;50(3):603-6 PMID: 17480009
  • Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. (Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):479-85 PMID: 17459050
  • Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. (Hulbert ML, Scothorn DJ, Panepinto JA, Scott JP, Buchanan GR, Sarnaik S, Fallon R, Chu JY, Wang W, Casella JF, Resar L, Berman B, Adamkiewicz T, Hsu LL, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun MR) J Pediatr 2006 Nov;149(5):710-2 PMID: 17095350
  • Attitudes regarding fertility preservation in female adolescent cancer patients. (Burns KC, Boudreau C, Panepinto JA) J Pediatr Hematol Oncol 2006 Jun;28(6):350-4 PMID: 16794502
  • The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease. (Pawar SS, Panepinto JA, Brousseau DC) Pediatr Blood Cancer 2008 Jan;50(1):111-3 PMID: 16619223
  • Perioperative management of sickle cell disease children undergoing adenotonsillectomy. (Duke RL, Scott JP, Panepinto JA, Flanary VA) Otolaryngol Head Neck Surg 2006 Mar;134(3):370-3 PMID: 16500429
  • Acute idiopathic thrombocytopenic purpura of childhood-diagnosis and therapy. (Panepinto JA, Brousseau DC) Pediatr Emerg Care 2005 Oct;21(10):691-5; quiz 696-8 PMID: 16215478
  • Health-related quality of life in children with sickle cell disease: child and parent perception. (Panepinto JA, O'Mahar KM, DeBaun MR, Loberiza FR, Scott JP) Br J Haematol 2005 Aug;130(3):437-44 PMID: 16042695
  • Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. (Panepinto JA, Brousseau DC, Hillery CA, Scott JP) Pediatr Blood Cancer 2005 Feb;44(2):182-6 PMID: 15390359
  • The effect of magnesium on length of stay for pediatric sickle cell pain crisis. (Brousseau DC, Scott JP, Hillery CA, Panepinto JA) Acad Emerg Med 2004 Sep;11(9):968-72 PMID: 15347549
  • Validity of the child health questionnaire for use in children with sickle cell disease. (Panepinto JA, O'Mahar KM, DeBaun MR, Rennie KM, Scott JP) J Pediatr Hematol Oncol 2004 Sep;26(9):574-8 PMID: 15342984
  • Pathophysiology of stroke in sickle cell disease. (Hillery CA, Panepinto JA) Microcirculation 2004 Mar;11(2):195-208 PMID: 15280092
  • Clinical features of a human Rac2 mutation: a complex neutrophil dysfunction disease. (Kurkchubasche AG, Panepinto JA, Tracy TF Jr, Thurman GW, Ambruso DR) J Pediatr 2001 Jul;139(1):141-7 PMID: 11445809
  • Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. (Ambruso DR, Knall C, Abell AN, Panepinto J, Kurkchubasche A, Thurman G, Gonzalez-Aller C, Hiester A, deBoer M, Harbeck RJ, Oyer R, Johnson GL, Roos D) Proc Natl Acad Sci U S A 2000 Apr 25;97(9):4654-9 PMID: 10758162 PMCID: PMC18288
  • Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. (Panepinto JA, Magid D, Rewers MJ, Lane PA) J Pediatr 2000 Feb;136(2):201-8 PMID: 10657826
  • Last update: 07/14/2015